<DOC>
	<DOC>NCT01458015</DOC>
	<brief_summary>The purpose of this study is to elucidate whether the additional mechanism of analgesia, i.e. reuptake inhibition of norepinephrine, of tapentadol leads to a change in different pain signs and symptoms in comparison to oxycodone.</brief_summary>
	<brief_title>Tapentadol Versus Oxycodon - a Mechanism-based Treatment Approach in Neuropathic Pain</brief_title>
	<detailed_description />
	<mesh_term>Neuralgia</mesh_term>
	<mesh_term>Peripheral Nervous System Diseases</mesh_term>
	<mesh_term>Oxycodone</mesh_term>
	<criteria>thermal or mechanical hyperalgesia chronic neuropathic pain (NRS =&gt; 6) nonspecific</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2014</verification_date>
	<keyword>QST</keyword>
	<keyword>neuropathic pain</keyword>
	<keyword>tapentadol pr</keyword>
	<keyword>oxycodone</keyword>
</DOC>